Cargando…
Rating analysis and BERTopic modeling of consumer versus regulated mHealth app reviews in Germany
Germany introduced prescription-based mobile health (mHealth) apps in October 2020, becoming the first country to offer them fully reimbursed by health insurance. These regulated apps, known as DiGAs, undergo a rigorous approval process similar to pharmaceuticals, including data protection measures...
Autores principales: | Uncovska, Marie, Freitag, Bettina, Meister, Sven, Fehring, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285024/ https://www.ncbi.nlm.nih.gov/pubmed/37344556 http://dx.doi.org/10.1038/s41746-023-00862-3 |
Ejemplares similares
-
Patient Acceptance of Prescribed and Fully Reimbursed mHealth Apps in Germany: An UTAUT2-based Online Survey Study
por: Uncovska, Marie, et al.
Publicado: (2023) -
Physicians’ Attitudes Toward Prescribable mHealth Apps and Implications for Adoption in Germany: Mixed Methods Study
por: Dahlhausen, Florian, et al.
Publicado: (2021) -
Consumers’ Preferences for Purchasing mHealth Apps: Discrete Choice Experiment
por: Xie, Zhenzhen, et al.
Publicado: (2023) -
Extending the Privacy Calculus to the mHealth Domain: Survey Study on the Intention to Use mHealth Apps in Germany
por: von Kalckreuth, Niklas, et al.
Publicado: (2023) -
Messaging strategies for communicating health-related information in social media—a content and effectiveness analysis of organ donation posts on Instagram in Germany
por: Olsacher, Alexandra, et al.
Publicado: (2023)